We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
18 October 2017
On September 7 2017 the government published the final pharmaceutical regulations resulting from the Comprehensive Economic and Trade Agreement (for further details please see "Publication of final regulations on patent linkage and term restoration relating to CETA").(1)
The final regulations comprise:
Both sets of regulations came into force on September 21 2017.
Health Canada has since published:
In addition, the Federal Court has published a practice notice regarding actions brought under the PMNOC regulations amendments.
For further information on this topic please contact Urszula Wojtyra or Nancy Pei at Smart & Biggar/Fetherstonhaugh's Toronto office by telephone (+1 416 593 5514) or email (firstname.lastname@example.org or email@example.com). Alternatively, please contact Daphne Lainson at Smart & Biggar/Fetherstonhaugh's Ottawa office by telephone (+1 613 232 2486) or email (firstname.lastname@example.org). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
(1) A webinar on the new regulations is available here.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.